Erudio Healtherudio.com
Sponsor
DualityBio trials: what clinicians said in public
No HCP commentary report on a trial sponsored by DualityBio yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by DualityBio: DB-1305-O-1001, DYNASTY-Breast02 and NCT05914116. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (DualityBio Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| DYNASTY-Breast02 NCT06018337 · DualityBio Inc. StandardView → | HER2-low, hormone receptor positive metastatic breast cancer | Phase 3 | Standard | View | |||
| NCT05914116 NCT05914116 · DualityBio Inc. FocusedView → | advanced/metastatic solid tumors | Phase 1/Phase 2 | Focused | View | |||
| DB-1305-O-1001 NCT05438329 · DualityBio Inc. FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||